Skip to content
OpenSampling

2023 · Biochemistry and biophysics reports · open access

Dried blood spot eluates are suitable for testing of SARS-CoV-2 IgG antibodies targeting Spike protein 1 and Nucleocapsid protein

Guttmann et al.

The finding, in our words

Dried blood spot eluates showed high agreement with serum for SARS-CoV-2 IgG against Spike and Nucleocapsid (r≈0.96; qualitative φ≈0.98–1.0) and remained stable after 6–8 hours of storage, supporting use of capillary DBS for serosurveys and decentralised testing.

A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.

Read the source ↗DOI 10.1016/j.bbrep.2023.101479PubMed 37125078

Labels

Papers that share these labels

  1. 2026

    The study validated a semi-quantitative protocol for Epstein-Barr virus serology using dried blood spots, demonstrating 98.8% sensitivity and 96.5% specificity compared to paired venous serum samples. The successful validation in a self-sampling cohort confirms the suitability of this patient-centric microsampling approach for large-scale seroprevalence studies and decentralised trials.

    A dried blood spot protocol for high-throughput semi-quantitative analysis of Epstein-Barr Virus VCA IgG and EBNA IgG serologies based on the Roche Elecsys system — Rubio-Acero et al., Virology journal · source ↗

    • blood
    • dried
    • capillary
    • dbs
    • self-collection
    • validation
    • venous-agreement
    • serology

  2. 2022

    Dried blood spot sampling achieved high sensitivity and specificity for SARS-CoV-2 antibody detection with strong correlation to paired serum, enabling virtually painless, decentralised specimen collection in community and remote settings where venepuncture is difficult.

    Evaluation of serological assays for SARS-CoV-2 antibody testing from dried blood spots collected from cohorts with prior SARS-CoV-2 infection — Catlett et al., Journal of clinical virology plus · source ↗

    • blood
    • dried
    • capillary
    • dbs
    • self-collection
    • validation
    • venous-agreement
    • serology

  3. 2021

    Capillary dried blood spot samples analysed with the Roche Elecsys anti-SARS-CoV-2 assay on COBAS 6000 systems agreed with paired serum results in 98.9% of cases and remained accurate at 86.7% after 9 days, supporting their use for decentralised COVID-19 serosurveillance and large-scale screening.

    Analysis of SARS-CoV-2 antibodies from dried blood spot samples with the Roche Elecsys Immunochemistry method — Fontaine & Saez, Practical laboratory medicine · source ↗

    • blood
    • dried
    • capillary
    • dbs
    • self-collection
    • validation
    • venous-agreement
    • serology

  4. 2021

    Capillary blood self-sampling showed near-perfect agreement with venous sampling for SARS-CoV-2 IgG detection, achieving a Cohen's kappa of 0.88. Samples remained stable at room temperature for seven days, and 38 of 39 participants successfully collected adequate volumes, supporting its use for decentralised serological testing.

    Self-sampling of capillary blood for SARS-CoV-2 serology — Brown et al., Scientific reports · source ↗

    • blood
    • liquid
    • dried
    • capillary
    • dbs
    • self-collection
    • validation
    • venous-agreement
    • serology

  5. 2026

    In AML and CLL, 91% of VAMS venetoclax results fell within 20% of plasma after individualised haematocrit correction; in home sampling, 18 of 21 patients self-sampled independently and 76% of returned samples were analysable, which shows home microsampling is workable, though the authors ask for multicentre validation.

    Clinical Validation of Venetoclax Volumetric Microsampling in Leukemia, with Whole-Blood-to-Plasma Conversion and Self-Microsampling Feasibility — Levens et al., Clinical Pharmacokinetics (paywalled) · source ↗

    • vams
    • venous-agreement
    • blood
    • dbs
    • tdm
    • self-collection
    • haematocrit
    • dried
    • oncology
    • capillary
    • validation